NEMEC SARAH (Senior VP, Finance and PAO) purchased 43.0% of their position (5K shares) of BOLT BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $2.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/5/2025ACC: 0000950170-25-063846
Officer· Senior VP, Finance and PAO
Since Jan 2026
+231K
Net shares
Net buyer
$2.8K
Total acquired
2
Open market trades
2B · 0S
3
Total transactions
231K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$0.64
Trade value
$1.59K
% of position
22.0%
6/6/2024
11.36K→13.86K
Common Stock
Direct
Shares
+2.50K
Price / share
$0.50
Trade value
$1.24K
% of position
17.7%
12/16/2024
14.13K→16.63K
Total
Net shares
+5K
Net value
$2.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2024 | P · Purchase | +2.50K | $0.64 | $1.59K | 22.0% | 11.36K | 13.86K |
| Common Stock Direct | 12/16/2024 | P · Purchase | +2.50K | $0.50 | $1.24K | 17.7% | 14.13K | 16.63K |
| Total | +5K | $2.83K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
226K shares
Shares
+226K
Strike price
0.351
Held after
226K
Exercisable
—
5/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock226K shares | 5/1/2025 | A · Award | +226K | 0.351 | — | 226K |